WeVote

Bill

Bill

PS 882

Para crear la “Ley para la Regulación y Supervisión del Uso de Células Madre de Puerto Rico”, a fines de establecer límites para garantizar que los procedimientos relacionados con células madre se realicen bajo estándares científicos, médicos y éticos que protejan a los pacientes de riesgos innecesarios y para otros fines relacionados.

2025-2028 Session

Puerto Rico establishes regulatory oversight for stem cell medical procedures to ensure they meet scientific and ethical standards, protecting patients from unproven or harmful treatments.

Referido a Comisión(es)
0
WeVote Research Nonpartisan
Bill Summary · PS 882

Legislative bill overview

Bill PS 882 establishes a regulatory framework for stem cell procedures in Puerto Rico, requiring them to meet scientific, medical, and ethical standards. The legislation aims to protect patients from unnecessary risks by creating oversight mechanisms and standardized protocols for stem cell-related treatments and research.

Why is this important

Stem cell therapies exist in a regulatory gray area globally, with some offering genuine medical promise while others are unproven or exploitative. Without clear standards, Puerto Rico residents could be vulnerable to unregulated clinics offering expensive, ineffective, or harmful treatments. Establishing oversight protects public health while potentially enabling legitimate therapeutic development.

Potential points of contention

  • Defining approved therapies: Determining which stem cell procedures meet standards requires expertise; overly restrictive definitions could limit access to emerging treatments, while loose standards defeat the bill's protective purpose
  • Regulatory authority and cost: Creating new supervisory infrastructure requires funding and institutional capacity; unclear which agency enforces rules or how compliance is verified
  • Industry impact: Existing stem cell clinics operating in Puerto Rico may face restrictions or closure; balancing patient protection against economic disruption from regulated businesses

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.